Subcutaneous delivery of the drug is a process of administering medication or medicine under the skin. In the subcutaneous drug delivery process, a small needle is used to inject the drug in the tissue present in between muscle and skin. The drug is injected in small amount, which varies between 1 mL to 2mL. For instance, insulin is widely administered through subcutaneous injection. The abdomen, arm, and thigh are the most common injection sites for subcutaneous injection.
The market for subcutaneous drug delivery devices is expected to grow during the forecast years due to the key factors such as rising prevalence of chronic diseases, high demand for minimally invasive drug delivery technology, and changing lifestyle. The market is expected to have several growth opportunities in the emerging nations where the market is estimated to adopt new technologies.
The "Global Subcutaneous Drug Delivery Devices Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of subcutaneous drug delivery devices market with detailed market segmentation by type, technology, distribution channel and geography. The global subcutaneous drug delivery devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading subcutaneous drug delivery devices market players and offers key trends and opportunities in the market.
The global subcutaneous drug delivery devices market is segmented on the basis of type, technology, distribution channel. Based on the type the market is segmented as prefilled injectable and fillable injectable. On the basis of technology the market is segmented as syringes, pens, patches and others. Further, based on the distribution channel the market is segmented as retail pharmacies, hospital pharmacies and online pharmacies.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global subcutaneous drug delivery devices market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The subcutaneous drug delivery devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting subcutaneous drug delivery devices market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the subcutaneous drug delivery devices market in these regions.
The reports cover key developments in the subcutaneous drug delivery devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from subcutaneous drug delivery devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for subcutaneous drug delivery devices in the global market. Below mentioned is the list of few companies engaged in the subcutaneous drug delivery devices market.
The report also includes the profiles of key subcutaneous drug delivery devices market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Insulet Corporation
- Enable Injections
- Consort Medical plc
- West Pharmaceutical Services, Inc
- Elcam Medical
- Amgen Inc
- Ypsomed AG
- scPharmaceuticals, Inc.
- Wilhelm Haselmeier GmbH and Co. KG
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.